Laparoscopy, robotic-assisted, and transanal techniques showed mixed success in high-risk rectal cancer patients, all falling short of expected outcomes. Primary outcome rates: 82.4% (laparoscopy), 64.3% (laparotomy), 74.7% (robotic), and 80.3% (transanal). 96% R0 resection rate across all techniques; no significant difference found. Conversion rates for minimally invasive methods remained consistent at 4.5%. Surgeons should consider […]
Category: General Surgery
Robotic Resection Outperforms Laparoscopic for Minor Liver Surgery
Robotic minor liver resection shows significant benefits over laparoscopic approaches for anterolateral segment surgeries. Median blood loss: 75 ml for robotic versus 100 ml for laparoscopic (p < 0.001). Major morbidity rates: 2.5% for robotic compared to 4.6% for laparoscopic (p = 0.004). Consider integrating robotic techniques to improve patient outcomes, especially for those with […]
New Tool Improves Fistula Risk Prediction in Pancreatoduodenectomy
A newly optimized classification model better predicts postoperative pancreatic fistula risk in patients undergoing pancreatoduodenectomy for periampullary tumors. Overall, the rate of clinically relevant pancreatic fistula was 22.2%, rising to 25.8% specifically for periampullary tumors. The original model showed moderate predictive performance (AUC = 0.632), but the adjusted version improved this to 0.672. Understanding these […]
Critical Margin Assessment in Pancreatic Cancer Surgery
Surgeons must prioritize evaluating specific resection margins in pancreatic cancer for better patient outcomes. Three key margins—superior-mesenteric vein (HR 1.48), medial (HR 1.92), and posterior (HR 1.65)—are significantly linked to disease-free survival. R1 status worsens survival in gemcitabine-treated patients (HR 1.97) but not with mFOLFOXIRI. Aim for thorough margin assessment focusing on these three areas […]
Watch-and-Wait for Rectal Cancer: Key Thresholds Identified
Watch-and-wait may be an option for rectal cancer patients, but specific conditions must be met to avoid worse outcomes. Salvage rates below 75% threaten disease-free survival; rates must stay above this for safety. Ten-year overall survival rates are similar: 83.0% for watch-and-wait vs. 81.5% for surgery. Monitoring regrowth rates is essential; if it exceeds 10% […]
EUS-RFA Offers Safe Option for Intraductal Neoplasms
EUS-guided radiofrequency ablation is a safe alternative for patients with branch-duct IPMNs showing worrisome features who cannot undergo surgery. Technical success was 100% in 62 procedures, with 98% achieving local control. Adverse events occurred in 27%, primarily mild abdominal pain; no deaths reported. This procedure effectively prevents cancer progression in patients unsuitable for traditional surgery. […]
Navigating Role Ambiguity in Surgical Education
In surgery, unclear team roles amid rising demands can lead to poor learning, burnout, and patient safety risks. Role ambiguity during high case volumes disrupts teamwork and learning, impacting both residents and advanced practice providers. Increased cognitive load and diminished educational opportunities are evident when residents face unclear responsibilities. Addressing these systemic issues can enhance […]
Laparoscopic Approach to Complex Liver Resection for Cholangiocarcinoma
Laparoscopic hemi-hepatectomy with portal vein resection offers effective options for patients with perihilar cholangiocarcinoma and portal vein involvement. Successfully completed in 450 minutes with minimal blood loss (200 ml). Achieved negative resection margins for a patient with Bismuth-Corlette type IV cholangiocarcinoma. Consider this approach for select patients to improve surgical outcomes while maintaining safety. Journal […]
Laparoscopic Sectionectomy: Safe, Low-Cost Technique In Action
A new laparoscopic posterior sectionectomy approach demonstrates effective liver resection while minimizing costs and resource use. Success with a single-energy device led to an R0 resection in a patient with a liver lesion. Operative time was 220 minutes with an estimated blood loss of only 60 ml. The patient was discharged on postoperative day 5, […]
Adjuvant Radiotherapy Boosts Survival in Node-Positive PDAC
Adjuvant radiotherapy improves survival for patients with margin-negative, node-positive pancreatic ductal adenocarcinoma after surgery. Median overall survival (OS) for adjuvant radiotherapy patients was 26.0 months versus 24.1 months for those without it (p < 0.001). Stage IIb patients benefited most, showing a notable OS improvement; no difference was seen in Stage III patients. Consider adjuvant […]